Thermo Fisher Scientific Inc. (TMO) to Issue Quarterly Dividend of $0.47 on July 15th

Thermo Fisher Scientific Inc. (NYSE:TMO) announced a quarterly dividend on Wednesday, May 20th. Stockholders of record on Monday, June 15th will be paid a dividend of 0.47 per share by the medical research company on Wednesday, July 15th. This represents a c) annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, June 15th.

Thermo Fisher Scientific has raised its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 8 consecutive years. Thermo Fisher Scientific has a dividend payout ratio of 7.6% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Thermo Fisher Scientific to earn $27.29 per share next year, which means the company should continue to be able to cover its $1.88 annual dividend with an expected future payout ratio of 6.9%.

Thermo Fisher Scientific Stock Down 1.4%

Thermo Fisher Scientific stock opened at $468.80 on Friday. The company has a market cap of $174.22 billion, a P/E ratio of 25.77, a price-to-earnings-growth ratio of 2.11 and a beta of 0.88. Thermo Fisher Scientific has a 1-year low of $385.46 and a 1-year high of $643.99. The company has a fifty day simple moving average of $479.14 and a 200 day simple moving average of $527.68. The company has a current ratio of 1.53, a quick ratio of 1.15 and a debt-to-equity ratio of 0.77.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, April 23rd. The medical research company reported $5.44 earnings per share for the quarter, beating analysts’ consensus estimates of $5.25 by $0.19. The business had revenue of $11.01 billion during the quarter, compared to the consensus estimate of $10.86 billion. Thermo Fisher Scientific had a net margin of 15.15% and a return on equity of 16.86%. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter last year, the firm earned $5.15 earnings per share. Thermo Fisher Scientific has set its FY 2026 guidance at 24.640-25.120 EPS. Research analysts anticipate that Thermo Fisher Scientific will post 24.86 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Gianluca Pettiti sold 400 shares of the firm’s stock in a transaction dated Monday, April 27th. The shares were sold at an average price of $462.66, for a total transaction of $185,064.00. Following the transaction, the chief operating officer directly owned 25,051 shares of the company’s stock, valued at approximately $11,590,095.66. This trade represents a 1.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.33% of the company’s stock.

Hedge Funds Weigh In On Thermo Fisher Scientific

A number of hedge funds have recently bought and sold shares of TMO. J. Stern & Co. LLP increased its position in Thermo Fisher Scientific by 58,006.4% during the fourth quarter. J. Stern & Co. LLP now owns 31,509,332 shares of the medical research company’s stock worth $18,258,082,000 after acquiring an additional 31,455,105 shares during the period. Norges Bank bought a new position in Thermo Fisher Scientific in the 4th quarter valued at about $3,072,744,000. Auto Owners Insurance Co increased its holdings in Thermo Fisher Scientific by 57,845.0% in the 4th quarter. Auto Owners Insurance Co now owns 2,427,896 shares of the medical research company’s stock valued at $1,406,844,000 after buying an additional 2,423,706 shares during the period. T. Rowe Price Investment Management Inc. increased its holdings in Thermo Fisher Scientific by 2,183.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 1,328,845 shares of the medical research company’s stock valued at $770,000,000 after buying an additional 1,270,643 shares during the period. Finally, Wellington Management Group LLP increased its holdings in Thermo Fisher Scientific by 88.9% in the 3rd quarter. Wellington Management Group LLP now owns 2,699,460 shares of the medical research company’s stock valued at $1,309,292,000 after buying an additional 1,270,191 shares during the period. 89.23% of the stock is owned by institutional investors.

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.